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ABSTRACT 
 
Coumarins are one of the most important classes of heterocycles that occupies prime position in synthetic and 
pharmaceutical chemistry due to their diverse applications. Broad spectrum of biological activity and their utility as 
useful synthons, coumarins have attracted researchers to work on this moiety, which is instrumental in the 
development of coumarin chemistry. This review article provides up to date information about the natural sources, 
developments, exploration of new methodologies and varied biological activities of coumarins.  
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INTRODUCTION 
 
The attention of organic chemists has been directed towards the field of heterocyclic chemistry, because of their 
valuable utilities in the synthesis of variety of biologically active derivatives. Nitrogen, oxygen and sulfur are the 
most common heteroatoms, but heterocyclic rings containing other hetero atoms are also widely known. A vast 
number of heterocyclic compounds are known and this number is increasing rapidly. Among the various classes of 
heterocycles, we are selected coumarin, pyrazole, pyrans, oxazines, oxadiazole and thiadiazoles for the present 
study. 
 
The fusion of pyrone ring with benzene nucleus gives rise to a class of heterocyclic compound known as 
benzopyrone, of which two distinct types are recognized. They are Benzo-α-pyrone (1) commonly called as 
coumarin, Benzo-γ-pyrone (2) commonly called as chromones, which differs from each other only in the position of 
the carbonyl group in the pyrone ring. 
 
 
Coumarin is chemically 2H-1-benzopyran-2-one and was first identified in 1820’s as an oxygen heterocycles, and is 
famous for its vanilla like or freshly-mowed hay fragrance. It was first isolated in 1822 from the tonka bean [1] and 
later from sweet clover, bison grass and woodruff. Coumarin is a crystalline white powder with a hay-like, sweet 
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aromatic creamy odor with certain nutty shadings, much used in synthetic form as a fragrance chemical for perfumes 
and for fragranced soaps and detergents.  
 
Coumarins are classified based on their chemical composition such as, simple coumarins which are hydroxylated, 
alkoxylated or alkylated on the benzene ring (e.g. Umbelliferone), Furanocoumarins, that contain a five membered 
furan ring attached to the coumarin moiety such as linear furanocoumarins (e.g. Xanthotoxin) and angular 
furanocoumarins (e.g. Angeligin). 
 
 
 
Pyrano coumarins containing a six membered ring attached to the coumarin moiety (e.g. Seselin  and Xanthyletin). 
Coumarins with substituents in the pyrone ring (e.g. Warfarin) [2]. 
 
 
Coumarin and its derivatives considered as the most active classes of heterocycles, which possess a broad spectrum 
of biological activity. They have been proven to be active as antibacterial [3], antifungal [4], anti-inflammatory [5], 
antidepressant [6], anti-HIV [7] and antitumour agents [8]. Moreover, coumarin and its related derivatives have been 
used as inhibitors of lipoxygenase (LOX) and cyclooxygenase (COX) pathways of arachidonic acid meyabolism [9].  
Besides the biological applications, the literature embodies their applications from the material view point such as 
additives in food, perfumes, cosmetics, optical brighteners and would dispersed fluorescent and laser dyes. Optical 
applications such as laser dyes, nonlinear optical chromophores, fluorescent whiteners, polymer science and solar 
energy collectors associated with coumarins have been extensively studied [10-13]. Coumarins are also found in 
selective microorganisms. Members of coumarins isolated from microbial sources are novobiocin from streptomycin 
and aflatoxin from Aspergillus species. They are used as enhancing agent in cosmetic products like soap, toothpaste, 
perfumes and alcoholic beverages [14]. It is also used as a neutralizer in rubber and plastic materials and also in 
paints and sprays to dilute the unpleasant odors [15]. 
 
NATURAL SOURCES OF COUMARINS 
Coumarins form elite classes of naturally occurring compounds, which occupy a special role in nature and interest in 
its chemistry continues unabated because of its usefulness as biologically active agents. They occur widely as 
secondary plant metabolites and are known to exhibit numerous interesting biological properties. More than 1800 
different natural coumarins have been discovered. Most of these coumarins are mono or deoxygenated in the 
aromatic ring [16]. The well-known natural compound containing coumarin nucleus is 7-hydroxycoumarin 
(umbelliferone) and is found in carrots, coriander and garden angelica. It has been used a sunscreen, a fluorescence 
indicator and as a dye indicator [17]. Warfarin is a naturally occurring compound containing the 4-hydroxy 
coumarin moiety. It has been isolated from woodruff as well as from lavender and is used to prevent clotting of 
blood in the veins, lungs or heart [18]. 
 
Recently six new coumarins have been isolated from the fruits and stem bark of Calophyllumdispar (Clusiaceae). 
The genus Calophyllum, which comprises of 200 species, is widely distributed in the tropical rain forest where 
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several species are used in folk medicine [19]. Coumarin derivatives ningalin B and lamellarin D were derived from 
the marine alkaloids, which exhibit HIV-1 integrace inhibition, immunomodulatory activity and cytotoxicity 
[20,21].  
 
 
(+)-Calanolide A isolated from Calophyllumlanigerum is a non-nucleoside reverse transcriptase inhibitor with 
potent activity against HIV-1 [22]. (+)-Cordatolide A, a tetracyclic coumarin isolated from the leaves C. 
cordatooblangum in 1985 [23]. (+)-Inophyllum B isolated from C. inophyllum was found to be most active against 
HIV-reverse transcriptase [24]. 
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Miglietta A and coworkers [25] isolated Geiparyarin from the leaves of Geijeraparviflora as a new drug which 
targets tubulin. They investigated the antimicrotubular and cytotoxic effects of new synthetic aromatic derivatives of 
geiparvarin and observed that these drugs inhibited the polymerization of microtubular protein.  
 
 
SYNTHESIS OF COUMARINS 
Because of their varied biological applications, the preparation of coumarin analogues has attracted attention of 
organic chemists. Numerous methods have been developed for the synthesis of Coumarins that includes via 
Pechmann condensation, Perkin reaction, Knoevenagel condensation, Wittig reaction etc. 
 
Pechmann condensation reaction was first reported by Pechmann and Duisberg in 1883. It has been widely 
employed for the synthesis of coumarins because of its preparative simplicity and inexpensive starting material. This 
method involves the reaction between phenol and β-keto ester in the presence of an acid catalyst (Scheme-1)[26]. 
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Vahid et al [27] reported a solvent free one-pot synthesis of coumarins from substituted phenols and ethyl 
acetoacetate catalyzed by FeF3 an environmentally friendly catalyst under microwave irradiation conditions 
(Scheme-2). The method offers high yield, short reaction time and easy isolation procedure. 
 
 
 
Sun and co-workers [28] have developed an alternative procedure for the pechmann condensation reaction 
employing Gallium (III) triiodide as a catalyst. This method has several advantages such as mild conditions, short 
reaction times, high yield and a simple operation. They carried out the reaction of 1-naphthol and ethyl acetoacetate 
in the presence of Gallium (III) triiodide as catalyst to obtain 4-methyl-2H-benzo[H]chromen-2-ones (Scheme-3).  
 
 
 
Jalal Albadi and co-workers [29] reported the synthesis of coumarin derivatives from phenol and ethyl acetoacetate 
in the presence of catalyst poly (4-vinylpyridine)-CuI under solvent free conditions at 80 °C (Scheme-4). The 
catalyst was prepared by refluxing the poly (4-vinylpyridine) and CuI under N2 atmosphere in ethanol. This catalyst 
can be recovered by simple filtration and recycled up to eight consecutive runs without any loss of their efficacy. 
 
 
 
Khaligh reported the green synthesis of coumarins from the mixture of phenols and β-keto esters at 40°C under 
solvent free conditions in the presence of [Msim] HSO4 as a catalyst (Scheme-5). The catalyst was recovered 
effectively by separating through decantation and is reused five times with only a slight decrease in the catalytic 
activity [30]. 
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The Perkin reaction provides other useful method for the synthesis of coumarins. For instance, Augustine et al [31] 
reported the one-pot synthesis of coumarins from salicylaldehyde and cyano acetic acid mediated by 
propylphosphonic anhydride (T3P) (Scheme-6). 
 
 
 
Synthesis of coumarins via Knoevenagel reaction involves the condensation of aromatic aldehydes and activated 
methylene compounds in the presence of amine. For instance, Singh and co-workers [32] reported a facile synthesis 
of 3-alkanoyl-2H-chromene-2-thiones by condensation of β-oxodithioesters and salicylaldehyde in the presence of 
piperidine under solvent free conditions (Scheme-7). 
 
 
  
Wittig reaction approach involves the reaction of an aromatic aldehyde or ketone with a phosphonate or 
phosphorous ylide. For instance, the reaction of salicylaldehyde and ethyl chloroacetate in the presence of 
triphenylphosphine and MgO/MeONa produced coumarins in good yields (Scheme-8) [33].  
 
 
 
Yavari and co-workers [34] reported the one-pot multistep reaction for the synthesis of coumarins from 4-
fluorophenol and dimethylacetylenedicarboxylate. In this reaction, the complex formed by the reaction of 
triphenylphosphine and dimethylacetylenedicarboxylate react with phenols to undergo aromatic electrophilic 
substitution, lactonization to provide 4-methoxycarbonyl coumarins (Scheme-9). 
 
 
Heck coupling involves the palladium catalysed reaction between aryl halides and alkenes to provide coupled 
alkenes in a well-established manner. The reaction is applied on 2-bromophenols and cinnamic acid esters to provide 
coumarins derivatives (Scheme-10) [35]. 
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Iso-coumarins have been of considerable interest due to their unique biological properties. The iso-coumarins were 
synthesized by the reaction of benzoic acid and alkynes using rhodium catalyst. Benzoic acids efficiently undergo 
oxidative coupling with alkynes through regioselective C-H bond cleavage under rhodium catalysis to form highly 
substituted iso-coumarin derivatives. Compared with the other conventional multistep synthetic methods, this direct 
annulations process is intensely step economical [36]. Jia and coworkers [37] have developed a method for the 
preparation of coumarins by palladium(II) catalyzed and trifluoroacetic acid mediated intramolecular 
cycloisomerization of arylated alkynoates  (Scheme-11). 
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Selles et al [38] synthesized highly substituted fused coumarins in two steps starting from the boronic acids and 
enoltriflates. Firstly, Pd(TPP)4 mediated coupling reaction produced the intermediate ester and then deprotection of 
phenolic hydroxyl group with BBr3 lead to phenol which readily lactonized to provide coumarins (Scheme-12). 
 
 
X. He et al [39] developed the FeCl3 catalyzed multicomponent reaction for the synthesis of coumarin-3-carboxylic 
esters using salicylaldehyde, Meldrum’s acid and alcohol as the starting materials (Scheme-13). The method is a 
highly economic and environmentally friendly way.  
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3-Bromocoumarins are synthesized by the treatment of α-halocarboxylic acid ester of salicylaldehyde by sodium or 
lithium tellurium triggered cyclization (Scheme-14). The reaction worked under non-basic conditions in THF. It was 
observed that the formation of coumarin was better with lithium telluride compared to sodium telluride [40]. 
 
 
Coumarins were synthesized form variety of electron rich phenols and electron rich cinnamates under mild reaction 
condition in the presence of trifluoroacetic acid at room temperature. Electron deficient phenols gave low yield of 
coumarin products, restricting the utility of this procedure [41]. 3-Aryl coumarin derivatives were synthesized in 
excellent yield by the reaction of 2-chloro-2-arylacetaldehyde with salicylaldehyde catalysed by N-hetero-cyclic 
carbene (NHC) via umpolung reaction (Scheme-15) [42]. The method has experimentally simple and mild. 
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Kaye et al [43] synthesized the coumarin derivatives by Baylis-Hillman methodology. Salicylaldehyde reacts with t-
butyl acrylate in the presence of DABCO used as a catalyst to form Baylis-Hillman adducts. These adducts were 
then reacted with HI in acetic acid to form 3-(iodomethyl)coumarin derivatives in good yields (Scheme-16). 
 
 
 
Polito and co-workers [44] showed a simple and facile synthesis of coumarin scaffolds via ring closing methathesis 
using Grubbs catalyst (Scheme-17). It involves the esterification of 2-vinylphenol with acryloyl chloride to form 
acrylic ester. The olefin metathesis reaction was conducted on acrylic acid ester in the presence of catalyst in 
dichloromethane. The method is an alternative to existing procedures for coumarin synthesis, where, near neutral 
conditions exist for the ring formation.  
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REACTIVITY OF COUMARINS 
Coumarin and its derivatives are highly reactive because of the aliphatic moiety present in the coumarin, it is likely 
to undergo ring opening at the acyl centre. Carbon-6 on the aromatic ring can undergo electrophilic attack such as 
Friedel-Crafts acylation, sulphonation leading to the formation of 6-substituted derivatives. A methyl substituent on 
the coumarin nucleus may react differently depending on the position of attachment. Phenol group present in the C-7 
position, it is easily undergo acylation, benzoylation and Friedel-Crafts reactions. 
 
Coumarin based benzothiazole derivative was synthesized from the coumarin-3-formyl chloride. The precursor 
coumarin-3-formyl chloride was prepared form the coumarin-3-carboxylic acid and thionyl chloride in the presence 
of pyridine. These formyl chlorides are treated with 2-amino benzothiazole and triethylamine in dichloromethane at 
room temperature furnished the target compound N-(benzo[d]thiazol-2-yl)-2-oxo-2H-chromene-3-carboxamide 
(Scheme-18)[45].   
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A series of coumarin appended formyl-pyrazoles were synthesized by a simple and accessible approach. The 
reaction of 8-acetyl-4-methyl-7-hydroxy coumarin and phenyl hydrazine hydrochlorides produces the intermediate 
compounds 8-acetyl-4-methyl-7-hydroxy coumarin hydrazones, which reacts with DMF in the presence of POCl3 
and yielded formyl-pyrazoles bearing coumarin moiety in good yield (Scheme-19). The synthesized new compounds 
and the intermediates 8-acetyl-4-methyl-7-hydroxy coumarin hydrazones prepared were screened in vitro for their 
antibacterial, antifungal antioxidant activities. The compounds having chloro substitution exhibited promising 
antifungal and antibacterial activity against the different organisms tested [46]. Later they were converted the formyl 
pyrazoles efficiently to fused pyrans [47]. 
 
  
Sahoo et al [48] effectively transformed 8-Amino-7-hydroxy-4-methyl coumarins to a series of 6-methyl-2-methyl-
8H-pyrano[2,3-e]benzoxazol-8-ones and 3-chloro-7-methyl-9H-pyrano[2,3-e]benzo-1, 4-oxazine-2, 9–diones 
(Scheme-20). 
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Farahi and co-workers [49] reported a convenient synthesis of new sulphonamide-substituted coumarins from the N-
sulfonylaldimines and 5,7-dihydroxy-4-methylcoumarin using NaOH (Scheme-21). The sulfonylaldimines were 
synthesized from the reaction of aromatic aldehydes and p-toluenesulfonamide in the presence of AlCl3. Further, 
5,7-dihydroxy-4-methylcoumarin was synthesized by the condensation of phloroglucinol and ethyl aceto acetate via 
the ZrOCl2/SiO2 catalyst.   
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Liang Han and co-workers [50] synthesized novel coumarin-type dyes from the 7-diethylamino-3-(4-
formylphenyl)coumarin. The 3-bromo-7-diethylaminocoumarin coupled with the 4-formylphenyl boric acid using 
tetrakis(triphenylphosphine)palladium in THF obtained the formyl coumarin. Satyanarayana Reddy et al [51] 
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synthesized a 7H-benzopyrano[3, 2-c] coumarins achieved by the mild base promted reaction of 4-chloro-3-
formylcoumarin with resorcinol in the presence of triethylamine and ethanol at room temperature (Scheme-22).  
 
3-Benzoyl-2H-chromen-2-one was treated with ethyl ayanoacetate under basic condition; afford ethyl 10-cyano-9-
hydroxy-6-oxo-7-phenyl-6H-benzo[c]chromen-8-caboxylate. The reaction pathway is assumed to proceed by 
nucleophillic addition of the carbanion to the ethylenic bond of 3-benzoyl-2H-chromen-2-one affording the expected 
pyranochromen,which in turn reacts with a second equivalent of ethyl cyanoacetateion, subsequent ring opening 
followed by recyclization and elimination of HCN affords the product (Scheme-23) [52]. 
 
Omaima and co-workers [53] developed a convenient approach to the preparation of coumarin based pyrimidines, 
pyridinesand pyrazole derivatives. These key reactions involved the intermediate formation of chalcones (3), a facile 
synthesis of these synthesized α, β-unsaturated ketones involves condensation of 3-acetyl-4-hydroxy-coumarin with 
the appropriate aldehydes. Acetyl coumarins were prepared by the reaction of 4-Hydroxy coumarin with acetyl 
chloride in the presence of pyridine or piperidine. 4-Aryl-2-amino-6-(4-hydroxycoumarin-3yl)-pyridine-3-
carbonitriles were prepared by the cyclization of the corresponding chalcones with malononitrile and ammonium 
acetate (4). On the other hand pyrimidin-2-thiones (5) were prepared by the cyclocondensation of the compound (3) 
with thiourea in 5% ethanolic potassium hydroxide solution. Further 5-Aryl-4,5-dihydro-3-(4-hydroxy-2-oxo-2H-
chromen-3-yl)-pyrazol-1-carbothioamide (6) were prepared by refluxing a mixture of compound (3) and 
thiosemicarbazide in ethyl alcohol in the presence of glacial acetic acid. Similarly N-acetylpyrazolines (7) were 
obtained by refluxing the key intermediate chalcones with hydrazine hydrate in glacial acetic acid (Scheme-24). 
 
Series of coumarin based traizole and pyrazole derivatives are synthesized from the key intermediate (7-Hydroxy-2-
oxo-2H-chromen-4-yl)-acetic acid hydrazide (8). Condensation of compound (8) with pentane-2,4-dione gave 4-[2-
(3,5-dimethyl-1H-pyrazol-1-yl)-2-oxoethyl]-7-hydroxy-2H-chromen-2-one (9), while with potassium isothiocyanate 
it gave a salt, which was converted directly to 7-hydroxy-4-[(5-mercapto-4H-1,2,4-triazol-3-yl)methyl]-2H-
chromen-2-one (10) by heating it in aqueous KOH followed by acidification with HCl in good yield. The 
intermediate (8) was prepared from (7-hydroxy-2-oxo-2H-chromen-4-yl)-acetic acid ester and 100% hydrazine 
hydrate (Scheme-25) [54]. 
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Triazole derivatives of 7-hydroxy-4-methyl coumarin was synthesized from the condensation of 7-(3-
chloropropoxy)-4-methyl-2H-chromen-2-one with 1,2,4-triazole. 7-(3-chloropropoxy)-4-methyl-2H-chromen-2-one 
was in turn prepared from the 7-hydroxy-4-methylcoumarin refluxed with 1-bromo-3-chloropropane in the presence 
of anhydrous potassium carbonate for twelve hours [55]. Pallabi et al [56] transformed the 4-Hydroxy coumarin to 
4-chloro-3-formyl coumarins with Vilsmeier reagent. They carried out one-pot three-component reaction of 4-
chloro-3-formylcoumarins, sodium azide and alkyl or aryl acetonitriles to get novel tetrazole fused pyrido[2,3-
c]coumarin derivatives. 1-Benzopyrano [3, 4-c]pyrrolidines are synthesized via 1,3-dipolar cycloaddition of in situ 
generated non stabilized azomethine ylide with 3-substituted coumarin and N-alkyl-α-amino acids (Scheme-26) 
[57].  
 
A series of (coumarin-3-yl)carbamates was synthesized by the mixture of 3-aminocoumarin dissolved in 
dichloromethane and pyridine. The mixture was cooled to 0°C.  The corresponding acid chloride was added drop 
wise to the mixture and the mixture was stirred at room temperature for 3 h. after completion of the reaction, solvent 
was evaporated and the solid obtained was purified to give the desired (coumarin-3-yl) carbamates [58]. A 
substituted pyrido[2,3-c]coumarin derivatives have been synthesized from 3-amino-coumarins, aromatic aldehydes 
and alkynes in the presence of 10 mol% molecular iodine in acetonitrile through one-pot Povarov reaction under 
reflux condition (Scheme-27) [59].  
 
 
A novel 3-(1H-benzo[d]imidazole-2-yl)-7-bromo-2H-chromen-2-one (12) was synthesized by the 7-bromo-2-oxo-
2H-chromene-3-carboxylic acid (11) and o-phenylenediamine in polyphosphoric acid under reflux condition for 12 
h. Along with the compound (12) , 7-((2-aminophenyl) amino)-2-oxo-2H-chromen-3-carboxylic acid (13) (Scheme-
28) was also obtained from this reaction which was separated through column chromatography. Compound (11) was 
synthesized by hydrolysis of 7-bromo-2-oxo-2H-chromene-3-carboxylic acid ethyl ester with sodium hydroxide 
[60].  
 
PHARMACEUTICAL APPLICATIONS OF COUMARINS 
Coumarins are of great interest due to their biological properties. In particular, their physiological, bacteriostatic and 
anti-tumor activity makes these compounds attractive for further backbone derivatisation and screening a novel 
therapeutic agent. Both coumarin and coumarin derivatives have shown promise potential inhibitors of cellular 
proliferation in various tumor cell lines [59]. In addition it has been shown that 4-hydroxycoumarin and 7-hydroxy 
coumarin inhibited cell proliferation in a gastric carcinoma cell line [61]. 
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Series of novel 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines (14) were synthesized by various 
substituted 3-aryl-1-(3-coumarinyl)propan-1-ones with phenyl hydrazine in the presence of hot pyridine. All the 
synthesized compounds were screened in vitro anti-inflammatory and analgesic activities. Compounds having 4-Cl 
and 2, 4-Cl exhibited significant anti-inflammatory activity in model of acute inflammation such as carrageenan-
induced rat paw edema compared with diclofenac as a standard drug. These compounds also found significant 
analgesic activity in acetic acid induced writhing model [62]. 
 
O
O
N
N
H
H
H
14
 
Pradeep kumar et al [63] reported the synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-
benzopyran-2-ones (15). They have evaluated the synthesized compounds for antibacterial and antifungal activity 
against bacterial and fungal strains. Among the synthesized compounds, compound having fluro substitution has 
shown good antimicrobial activity. 
 
Mesuol (16) and isomesuol (17) are the 4-phenyl coumarins, isolated from the tree Marilapluricostata, suppress 
HIV-1 replication in Jurkat T cells [64]. Mesuol inhibits TNFα-induced HIV-1-LTR transcriptional activity by 
targeting the nuclear factor –κB (NF-κB) pathway. Mesuol does not prevent either the binding of NF-κB to DNA or 
the phosphorylation and degradation of NF-κBp65 subunit in TNFα-stimulated cells. These results highlight the 
potential of the NF-κB transcription factor as a target for anti-HIV-1 compounds such as 4-phenyl coumarins, which 
could serve as lead compounds for the development of additional therapeutic approaches against AIDS. 
 
 
Series of chalcone-coumarin derivatives linked by the 1,2,3-triazole ring (18) were synthesized through the azide 
and alkyne dipolar cycloaddition. These molecules were evaluated for their cytotoxic activity against cancer cell 
lines (HuCCA-1, HepG2, A549 and MOLT-3). Among these triazole hybrid, the 2,3-dimethoxy derivatives 
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containing triazole ring at position 3 shown to be the most potent cytotoxic compound against MOLT-3 cells lines 
without affecting normal cells [65]. 
 
 
Ranjana et al [66] synthesized a series of novel 2-(5-hydroxy 5-trifluoromethyl-4,5-dihydromethyl-4,5-
dihydropyrazol-1-yl)-4-(coumarin-3-yl)thiazoles (19)  by condensing 3-(2-bromoacetyl)coumarins with 5-hydroxy-
5-trifluromethyl-4,5-dihydropyrazol-1-thiocarboxamides. All these new derivatives were screened for their 
antibacterial activity. The minimum inhibitory concentration of the synthesized compounds against different 
bacterial strains was determined by macro dilution tube method. Among these compounds, compound having Cl and 
F substituents were found to be most effective against E.coli and P.mirabilis when compared to the standard drug 
cefixime. 
 
A new class of iodinated-4-aryloxymethylcoumarins (20, 21) have been synthesized from the various 4-
bromomethylcoumarins with 2-iodophenol, 3-iodophenol and 4-iodophenol respectively. All these compounds were 
screened for their in vitro anticancer activity against two cancer cell lines MDA-MB human adenocarcinoma 
mammary gland and A-549 human lung carcinoma by using MTT assay for the determination of MIC values. 
Among these, compound having chlorine at 6th and 7th position on coumarin and iodine at 4th position on phenoxy 
moiety exhibited potent anticancer activity [67]. 
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Koneni et al [68] synthesized a series of coumarin based aminopyran derivatives were synthesized and evaluated for 
their antidepressant effect on Swiss albino mice. Among the series, compound (22) exhibited significant activity in 
Forced Swimming Test (FST) at a very low dose of 0.5 mg/kg reduced the time of immobility by 86.5% as 
compared to the standard drug fluoxetine which reduced the immobility time by 69.8% at the dose of 20 mg/kg. 
Further all active compounds were screened for tail suspension test (TST). From this, it was proved that these 
hybrids did not produce any motor impairment effects. Hence coumarin-aminopyran derivatives may have potential 
therapeutic value for the management of mental depression. 
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Series of novel coumarin-3-carboxamides (23) were synthesized and evaluated for their in vitro antioxidant activity 
and in vivo anti-inflammatory activity. These carboxamide coumarins possessed potent antioxidant and anti-
inflammatory activities. On the basis of results, structure-activity relationships were developed in order to define the 
structural features required for activity [69]. Patel R B and co-workers synthesized a novel 3,4-dimethoxy phenyl 
ethyl 1,3,5-triazinyl thiourea derivative (PETT) (24) as antibacterial and anti-HIV agents [70]. 
 
2-(substituted phenyl)-3-(4-methylcoumarinyl-7-oxyacetamido)-5-carboxymethyl-4-thiazolidione (25) was 
synthesized by the 4-methylcoumarinyl-7-ocyacetic acid [(substituted phenyl methylene)] hydrazides and thiomalic 
acid in glacial acetic acid under reflux condition. After completion of the reaction, the mixture was dissolved in 
sodium bicarbonate solution and re-precipitated by hydrochloric acid and recrystallized from ethanol. The obtained 
product was evaluated for antioxidant activity by DPPH assay. Among this, compound with unsubstituted phenyl 
substituent showed more than 95% antioxidant activity compared to standard ascorbic acid [71]. 
 
 
 
CONCLUSION 
 
In the present review, attempt has been made to present the source, synthetic strategies, reactions and 
pharmaceutical applications of coumarins. Wide range of natural sources and new coumarin analogues are being 
discovered or synthesized on a regular basis. The coumarins are of great attention due to their therapeutic property. 
Their physiological, bacteriostatic, antioxidant, antitumor and other pharmaceutical properties make the coumarins 
as novel class for therapeutic applications. Synthetic procedure and clinical applications of coumarins for the 
treatment of several diseases were critically discussed.  
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